Medicine
Lisinopril 5 mg tablet
Lisinopril 5 mg tablet is a generic prescription medicine for oral use, made by 29 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Protect from moisture, freezing and excessive heat. Store at controlled room…
Key facts
- Active ingredient (INN)
- Lisinopril
- Brand
- Sold under the generic name
- Strength
- 5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 1000 tablets, 95238 tablets and 123 more
- Manufacturers
- Aurobindo PharmaIndiaCamber PharmaceuticalsIndiaLupinIndiaAvet PharmaceuticalsIndiaExelan PharmaceuticalsSolco HealthcareActavis PharmaChartwell RX29 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Protect from moisture, freezing and excessive heat. Store at controlled room temperature, 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C09AA03 Lisinopril
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 July 2002
- Identifiers
- RxCUI 197884, 205326, 311353 +3DailyMed set ID 1bc69836-a659-4e3b-84a7-a00b7c4dc268, c6c55efa-36bd-4613-98ca-2eb589a31e53, bf59ff89-a9fa-4fe3-b167-a5d0cba9e438 +37NDC 76282-418, 23155-877, 43063-074 +37Application ANDA203508, ANDA076102, ANDA076164 +7
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 29 labelers. The register lists 126 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 31722-176-01 | Camber PharmaceuticalsIndia | 17 August 2021 |
| 1000 tablet in 1 bottle | 31722-176-10 | Camber PharmaceuticalsIndia | 17 August 2021 |
| 95238 tablet in 1 carton | 31722-176-31 | Camber PharmaceuticalsIndia | 17 August 2021 |
| 100 tablet in 1 bottle | 65862-038-00 | Aurobindo PharmaIndia | 22 February 2006 |
| 100 tablet in 1 bottle | 65862-038-01 | Aurobindo PharmaIndia | 22 February 2006 |
| 500 tablet in 1 bottle | 65862-038-05 | Aurobindo PharmaIndia | 22 February 2006 |
| 30 tablet in 1 bottle | 65862-038-30 | Aurobindo PharmaIndia | 22 February 2006 |
| 1000 tablet in 1 bottle | 65862-038-99 | Aurobindo PharmaIndia | 22 February 2006 |
| 100 tablet in 1 bottle | 23155-877-01 | Avet PharmaceuticalsIndia | 6 September 2023 |
| 1000 tablet in 1 bottle | 23155-877-10 | Avet PharmaceuticalsIndia | 6 September 2023 |
| 100 tablet in 1 bottle | 68180-513-01 | LupinIndia | 13 January 2006 |
| 1000 tablet in 1 bottle | 68180-513-03 | LupinIndia | 13 January 2006 |
| 5000 tablet in 1 pouch | 68180-513-30 | LupinIndia | 13 January 2006 |
| 100 tablet in 1 bottle | 76282-418-01 | Exelan Pharmaceuticals | 22 March 2017 |
| 500 tablet in 1 bottle | 76282-418-05 | Exelan Pharmaceuticals | 22 March 2017 |
| 1000 tablet in 1 bottle | 76282-418-10 | Exelan Pharmaceuticals | 22 March 2017 |
| 180 tablet in 1 bottle | 76282-418-18 | Exelan Pharmaceuticals | 22 March 2017 |
| 30 tablet in 1 bottle | 76282-418-30 | Exelan Pharmaceuticals | 22 March 2017 |
| 45 tablet in 1 bottle | 76282-418-45 | Exelan Pharmaceuticals | 22 March 2017 |
| 90 tablet in 1 bottle | 76282-418-90 | Exelan Pharmaceuticals | 22 March 2017 |
| 100 tablet in 1 bottle | 76282-729-01 | Exelan Pharmaceuticals | 7 April 2023 |
| 500 tablet in 1 bottle | 76282-729-05 | Exelan Pharmaceuticals | 7 April 2023 |
| 1000 tablet in 1 bottle | 76282-729-10 | Exelan Pharmaceuticals | 7 April 2023 |
| 180 tablet in 1 bottle | 76282-729-18 | Exelan Pharmaceuticals | 7 April 2023 |
| 30 tablet in 1 bottle | 76282-729-30 | Exelan Pharmaceuticals | 7 April 2023 |
| 45 tablet in 1 bottle | 76282-729-45 | Exelan Pharmaceuticals | 7 April 2023 |
| 90 tablet in 1 bottle | 76282-729-90 | Exelan Pharmaceuticals | 7 April 2023 |
| 100 tablet in 1 bottle | 43547-352-10 | Solco healthcare | 1 November 2011 |
| 1000 tablet in 1 bottle | 43547-352-11 | Solco healthcare | 1 November 2011 |
| 30 tablet in 1 bottle | 43547-415-03 | Solco healthcare | 30 August 2017 |
| 45 tablet in 1 bottle | 43547-415-04 | Solco healthcare | 30 August 2017 |
| 90 tablet in 1 bottle | 43547-415-09 | Solco healthcare | 30 August 2017 |
| 100 tablet in 1 bottle | 43547-415-10 | Solco healthcare | 30 August 2017 |
| 1000 tablet in 1 bottle | 43547-415-11 | Solco healthcare | 30 August 2017 |
| 2500 tablet in 1 bottle | 43547-415-25 | Solco healthcare | 30 August 2017 |
| 500 tablet in 1 bottle | 43547-415-50 | Solco healthcare | 30 August 2017 |
| 100 tablet in 1 bottle, plastic | 0591-0406-01 | Actavis Pharma | 1 July 2002 |
| 1000 tablet in 1 bottle, plastic | 0591-0406-10 | Actavis Pharma | 1 July 2002 |
| 300 tablet in 1 bottle | 62135-641-31 | Chartwell RX | 7 June 2023 |
| 90 tablet in 1 bottle | 62135-641-90 | Chartwell RX | 7 June 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 29 December 1987 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Lisinopril 5 mg tablet.
Other strengths and forms of Lisinopril
Clinical summary
Lisinopril is an angiotensin converting enzyme inhibitor indicated for treatment of hypertension in adults and pediatric patients 6 years of age and older, among other approved uses. It is available as tablets and oral solution. MedsAcross supplies Lisinopril for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about LisinoprilFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Zestril prescribing information (Upsher-Smith Laboratories) · U.S. National Library of Medicine, DailyMed
Need Lisinopril 5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.